Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
AL-4943A ophthalmic solution vehicle
DRUG
2 trials
Sponsors
Alcon Research
Conditions
Allergic Conjunctivitis
Phase 3
A Six-Week Safety Study of an Investigational Ophthalmic Solution
Completed
NCT01698814
Alcon Research
Allergic Conjunctivitis
Start: 2012-10-31
End: 2013-01-31
Updated: 2014-03-27
Efficacy and Safety of an Ophthalmic Solution in Patients With Allergic Conjunctivitis
Completed
NCT01743027
Alcon Research
Allergic Conjunctivitis
Start: 2013-01-31
End: 2013-07-31
Updated: 2014-08-11
Related Papers
Treating Allergic Conjunctivitis: A Once-daily Medication that Provides 24-hour Symptom Relief
Allergy & Rhinology
2016-01-01
19 citations
Phase 3 Randomized Double-Masked Study of Efficacy and Safety of Once-Daily 0.77% Olopatadine Hydrochloride Ophthalmic Solution in Subjects With Allergic Conjunctivitis Using the Conjunctival Allergen Challenge Model
Cornea
2015-08-12
19 citations